相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus
Zheng Li et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Alzheimer's Disease, Cholesterol, and Statins: The Junctions of Important Metabolic Pathways
Tiago Silva et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
In vitro biological assessment of berberis vulgaris and its active constituent, berberine: antioxidants, anti-acetylcholinesterase, anti-diabetic and anticancer effects
Abeer E Abd El-Wahab et al.
BMC Complementary and Alternative Medicine (2013)
Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease
Matilde Yanez et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
A comparative study on the hepatoprotective action of bear bile and coptidis rhizoma aqueous extract on experimental liver fibrosis in rats
Ning Wang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
Nitric Oxide: Target for Therapeutic Strategies in Alzheimers Disease
A. P. Fernandez et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Tumor Necrosis Factor and Alzheimer's Disease: A Cause and Consequence Relationship
Vivek Sharma et al.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Retinol Binding Protein-4 Circulating Levels Were Higher in Nonalcoholic Fatty Liver Disease Vs. Histologically Normal Liver From Morbidly Obese Women
Ximena Terra et al.
Obesity (2012)
Berberine inhibits dyslipidemia in C57BL/6 mice with lipopolysaccharide induced inflammation
Hong-Bo Xiao et al.
PHARMACOLOGICAL REPORTS (2012)
Molecular Basis of Inhibitory Activities of Berberine against Pathogenic Enzymes in Alzheimer's Disease
Hong-Fang Ji et al.
SCIENTIFIC WORLD JOURNAL (2012)
Decrease in the production of beta-amyloid by berberine inhibition of the expression of beta-secretase in HEK293 cells
Feiqi Zhu et al.
BMC NEUROSCIENCE (2011)
Linking lipids to Alzheimer's disease: cholesterol and beyond
Gilbert Di Paolo et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction
Doaa A. Ghareeb et al.
METABOLIC BRAIN DISEASE (2011)
Berberine derivatives, with substituted amino groups linked at the 9-position, as inhibitors of acetylcholinesterase/butyrylcholinesterase
Ling Huang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Insulin metabolism and the risk of Alzheimer disease The Rotterdam Study
E. M. C. Schrijvers et al.
NEUROLOGY (2010)
Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation
Crystal M. Cordes et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production
Huaqi Xiong et al.
NEUROBIOLOGY OF DISEASE (2008)
Combination of simvastatin with berberine improves the lipid-lowering efficacy
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Mohammed Qatanani et al.
GENES & DEVELOPMENT (2007)
Neuronal transcriptome of Aplysia:: neuronal compartments and circuitry
Leonid L. Moroz et al.
CELL (2006)
Statins inhibit the dimerization of β-secretase via both isoprenoid-and cholesterol-mediated mechanisms
Richard B. Parsons et al.
BIOCHEMICAL JOURNAL (2006)
Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation
JK Reddy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Nitric oxide as a cellular antioxidant: A little goes a long way
SG Hummel et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
The regulation of chondrocyte function by proinflammatory mediators -: Prostaglandins and nitric oxide
MB Goldring et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2004)
Intramembrane proteotysis: Theme and variations
MS Wolfe et al.
SCIENCE (2004)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
Statin-associated myopathy
PD Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer β-amyloid peptide in vitro and in patients
JD Buxbaum et al.
FRONTIERS IN BIOSCIENCE (2002)
Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents
KH Janbaz et al.
FITOTERAPIA (2000)
分享论文
